
CEO of Home Care · CLOVER HEALTH INVESTMENTS, CORP. /DE · Class A Common Stock
Open-market sale
$380K reported value · 8.1% of prior position
Disclosed 1 business day after execution (deadline: 2)
First recorded trade by this actor in this security
No clustered activity in the dataset
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Oldakowski Joseph FrankChief Accounting Officer | Grant or award | A | — 186.4K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 13 | Thornton Joseph ClayChief Financial Officer | Grant or award | A | — 328.9K sh | Nov 6, 2026 traded Nov 4, 2026 | |
| 19 | Soares KarenChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $90K 19.3K sh | Oct 20, 2026 traded Oct 20, 2026 | |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $18K 4,066 sh | Oct 20, 2026 traded Oct 19, 2026 | |
| 19 | Wai ConradCEO, Counterpart Health | Open-market sale · 10b5-1 plan | SELL | $111K 23.6K sh | Oct 19, 2026 traded Oct 15, 2026 | |
| 22 | Toy AndrewDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $291K 62.2K sh | Oct 19, 2026 traded Oct 15, 2026 | |
| 16 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $86K 18.3K sh | Oct 19, 2026 traded Oct 15, 2026 | |
| 19 | Soares KarenChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $69K 14.7K sh | Oct 19, 2026 traded Oct 15, 2026 | |
| 20 | Thornton Joseph ClayInterim CFO | Open-market sale · 10b5-1 plan | SELL | $21K 4,591 sh | Oct 19, 2026 traded Oct 15, 2026 | |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $9,288 2,006 sh | Oct 7, 2026 traded Oct 7, 2026 | |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $8,760 1,921 sh | Sep 18, 2026 traded Sep 17, 2026 | |
| 33 | Wai ConradCEO, Counterpart Health | Open-market sale · 10b5-1 plan | SELL | $1.42M 300.0K sh | Sep 16, 2026 traded Sep 15, 2026 | |
| 13 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $44K 9,273 sh | Sep 15, 2026 traded Sep 15, 2026 | |
| 20 | Soares KarenChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $33K 6,846 sh | Sep 15, 2026 traded Sep 15, 2026 | |
| 43 | Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER | Open-market sale | SELL | $103K 20.0K sh | Sep 14, 2026 traded Sep 14, 2026 | |
| 13 | Soares KarenChief Legal Officer | Grant or award | A | — 108.7K sh | Aug 13, 2026 traded Aug 12, 2026 | |
| 9 | Thornton Joseph ClayInterim CFO | Grant or award | A | — 54.3K sh | Aug 13, 2026 traded Aug 12, 2026 | |
| 11 | Toy AndrewDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $408K 87.8K sh | Aug 10, 2026 traded Aug 10, 2026 | |
| 1 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $11K 2,360 sh | Jun 18, 2026 traded Jun 17, 2026 | |
| 6 | Reynoso Jamie L.CEO, Medicare Advantage | Open-market sale · 10b5-1 plan | SELL | $36K 7,289 sh | Jun 11, 2026 traded Jun 11, 2026 |
Read directly from the primary public document; every field below is as reported by the filer.
Value = shares × reported price per share
= $379,750
Priest Brady Patrick filed this Form 4 reporting a open-market sale of CLOV on Mar 4, 2026. It became public on Mar 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
No field has changed since this record was first ingested.
No material filings recorded for this issuer.